共 71 条
- [2] A phase II trial of intraperitoneal EGEN-001, an IL-12 plasmid formulated with PEG-PEI-cholesterol lipopolymer in the treatment of persistent or recurrent epithelial ovarian, fallopian tube or primary peritoneal cancer: A Gynecologic Oncology Group study [J]. GYNECOLOGIC ONCOLOGY, 2014, 133 (03) : 433 - 438
- [4] Reliability of adverse symptom event reporting by clinicians [J]. QUALITY OF LIFE RESEARCH, 2012, 21 (07) : 1159 - 1164
- [6] Wisconsin Ginseng (Panax quinquefolius) to Improve Cancer-Related Fatigue: A Randomized, Double-Blind Trial, N07C2 [J]. JNCI-JOURNAL OF THE NATIONAL CANCER INSTITUTE, 2013, 105 (16): : 1230 - 1238
- [7] Adverse Symptom Event Reporting by Patients vs Clinicians: Relationships With Clinical Outcomes [J]. JNCI-JOURNAL OF THE NATIONAL CANCER INSTITUTE, 2009, 101 (23): : 1624 - 1632